February 27 2012 - Is the sale of “work product” to pharmaceutical companies making us sicker and poorer?
As Bill C-12 (legislation that would amend PIPEDA) continues to languish in Parliament, Murray Long revisits the controversial issue of work product information, questioning whether the proposed amendment in Bill C-12 is the best approach for dealing with this issue. Murray suggests that the Quebec model may be a better alternative.